Zhihao Lu, Wenting Du, Xi Jiao, Yanni Wang, Zhang Zhang, Lin Shen. "Reply to: “
                    <i>NOTCH1</i>
                    : A Potential New Biomarker in the Era of Immunotherapy?” and “Caution in Interpreting
                    <i>NOTCH1</i>
                    Mutation as a Predictive Biomarker of Tislelizumab Response in Esophageal Squamous Cell Carcinoma”." Journal of Clinical Oncology, 2025. doi:10.1200/jco-25-01535